Cholesterol Metabolism

Overview

Cholesterol is a 27-carbon lipid molecule that is essential for life. It is a structural component of all animal cell membranes, modulating membrane fluidity and permeability. More importantly for the peptide field, cholesterol is the obligate precursor for the synthesis of all steroid hormones — including cortisol, aldosterone, testosterone, estradiol, and progesterone — as well as bile acids and vitamin D. Without adequate cholesterol, the adrenal glands cannot produce cortisol, the gonads cannot produce sex hormones, and the HPG axis cannot function.

Cholesterol homeostasis involves a balance between endogenous synthesis (primarily hepatic), dietary absorption, lipoprotein transport, and excretion. Dysregulation of this balance is a primary driver of atherosclerotic cardiovascular disease.

Biosynthesis: The Mevalonate Pathway

All nucleated cells can synthesize cholesterol, but the liver is the dominant site of production. The pathway begins with acetyl-CoA and proceeds through more than 30 enzymatic steps:

1. Acetyl-CoA to HMG-CoA — Two molecules of acetyl-CoA condense to form acetoacetyl-CoA, which combines with a third acetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA).
2. HMG-CoA reductase (rate-limiting step) — HMG-CoA is reduced to mevalonate by HMG-CoA reductase. This is the target of statin drugs, the most widely prescribed class of cholesterol-lowering medications.
3. Mevalonate to squalene — A series of phosphorylation and decarboxylation reactions convert mevalonate through isopentenyl pyrophosphate, geranyl pyrophosphate, and farnesyl pyrophosphate to squalene.
4. Squalene to cholesterol — Squalene is cyclized to lanosterol and then converted to cholesterol through approximately 19 additional steps.

Cholesterol as a Hormone Precursor

Cholesterol is converted to pregnenolone in the mitochondria of steroidogenic tissues (adrenal cortex, gonads, placenta) by the enzyme CYP11A1 (cholesterol side-chain cleavage enzyme). Pregnenolone is then the precursor for all steroid hormones:

• Glucocorticoids — Cortisol, synthesized in the adrenal zona fasciculata under ACTH stimulation. See Adrenal Function and HPA Axis.
• Mineralocorticoids — Aldosterone, from the adrenal zona glomerulosa, regulating sodium and potassium balance.
• Androgens — Testosterone and DHEA, from the adrenal zona reticularis and Leydig cells of the testis. Regulated by the HPG axis via GnRH and LH.
• Estrogens — Estradiol, produced by aromatization of testosterone in the ovaries and peripheral tissues.
• Progestogens — Progesterone, from the corpus luteum and placenta.

The peptide hormones ACTH, LH, FSH, and GnRH ultimately control steroid hormone production by regulating the availability and conversion of cholesterol in steroidogenic cells. Peptide-based interventions in the HPG axis (such as gonadorelin, kisspeptin, leuprolide, and triptorelin) indirectly modulate cholesterol flux through steroidogenic pathways.

Lipoprotein Transport

Cholesterol is water-insoluble and is transported in the blood within lipoprotein particles:

• Chylomicrons — Transport dietary cholesterol and triglycerides from the intestine to peripheral tissues.
• VLDL — Transport endogenous triglycerides and cholesterol from the liver to peripheral tissues.
• LDL — The primary carrier of cholesterol to peripheral tissues. LDL is taken up by cells via the LDL receptor through receptor-mediated endocytosis. Elevated LDL cholesterol is a major risk factor for atherosclerosis.
• HDL — Mediates reverse cholesterol transport, carrying cholesterol from peripheral tissues back to the liver for excretion. Higher HDL levels are associated with cardiovascular protection.

Regulation

Cholesterol homeostasis is maintained by feedback mechanisms centered on the transcription factor SREBP-2 (sterol regulatory element-binding protein 2):

• When intracellular cholesterol is low, SREBP-2 is activated and upregulates HMG-CoA reductase and the LDL receptor, increasing both synthesis and uptake.
• When intracellular cholesterol is high, SREBP-2 processing is inhibited, reducing synthesis and uptake.
• Oxysterols (oxidized cholesterol derivatives) activate LXR receptors, promoting cholesterol efflux via ABCA1 transporters.

Peptide-Relevant Clinical Connections

• Statin therapy — Statins inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis. The resulting decrease in intracellular cholesterol upregulates LDL receptors, lowering blood LDL. Statins can modestly reduce testosterone levels by limiting cholesterol availability for steroidogenesis, which is relevant to hormone optimization protocols.
• PCSK9 inhibitors — PCSK9 is a protein that promotes LDL receptor degradation. Monoclonal antibodies (evolocumab, alirocumab) and the small interfering RNA inclisiran block PCSK9, increasing LDL receptor density and lowering LDL cholesterol. Peptide-based PCSK9 inhibitors are in development.
• Cardiovascular peptides — Natriuretic peptides (ANP, BNP) have lipid-modulating effects, promoting lipolysis and fatty acid oxidation. See Peptides in Cardiology.

See Also

• Adrenal Function — Cholesterol-dependent cortisol production
• HPG Axis — Cholesterol-dependent sex hormone production
• Fatty Acid Synthesis — The related lipid biosynthetic pathway
• Insulin — Hormonal regulator of lipid metabolism
• Hormone Optimization Protocol — Practical considerations for steroid hormones